Microbot Medical Inc buy The Goldman Sachs Group, Inc.
Start price
24.01.24
/
50%
€1.17
Target price
24.01.25
€5.51
Performance (%)
64.36%
End price
25.01.25
€1.92
Summary
This prediction ended on 25.01.25 with a price of €1.92. With a performance of 64.36% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Microbot Medical Inc | -14.000% | -14.000% | -21.451% |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Microbot Medical Inc diskutieren
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
In the thread Trading Microbot Medical Inc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten